Skip to main content
Equibles

Walleye Trading LLC

Position in VTRS — Viatris Inc

CIK 1388391 NEW YORK, NY
Back to VTRS Full portfolio

Position in VTRS

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$574,093
-$111,620 QoQ
Shares Held
36,152
-28.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#387
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Derivatives in VTRS

reported options exposure · as of Jun 30, 2026
CallValue
$111,160
CallShares
7,000
PutValue
$2,434,404
PutShares
153,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Walleye Trading LLC holds $100,878,368 across 9 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,002,966 $72,073,136
2 TEVA
Teva Pharmaceutical Industries Ltd
 471,514 $15,974,894
3 HIMS
Hims & Hers Health, Inc.
 287,756 $9,976,500
4 ELAN
Elanco Animal Health Inc
 42,073 $1,035,416
5 BHC
Bausch Health Companies Inc.
 135,199 $666,531
6 VTRS
Viatris Inc
This page 		36,152 $574,093
7 TLRY
Tilray Brands, Inc.
 63,168 $283,624
8 NBIX
Neurocrine Biosciences Inc
 1,200 $202,248

All Filings in VTRS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,434,404 153,300
2026-06-30 $574,093 36,152
2026-06-30 $111,160 7,000
2026-03-31 $1,137,542 84,200
2026-03-31 $685,713 50,756
2026-03-31 $1,092,959 80,900
2025-12-31 $126,990 10,200
2025-12-31 $232,815 18,700
2025-09-30 $636,570 64,300
2025-09-30 $1,274,130 128,700
2025-06-30 $942,115 105,500
2025-06-30 $567,948 63,600
2025-03-31 $108,875 12,500
2025-03-31 $913,679 104,900
2024-12-31 $993,510 79,800
2024-12-31 $115,934 9,312
2024-12-31 $1,103,070 88,600
2024-09-30 $233,361 20,100
2024-09-30 $856,818 73,800
2024-06-30 $554,886 52,200
2024-06-30 $1,155,481 108,700
2024-03-31 $968,334 81,100
2024-03-31 $1,217,880 102,000
2023-12-31 $1,626,666 150,200
2023-12-31 $798,171 73,700
2023-12-31 $647,796 59,815
2023-09-30 $1,569,761 159,205
2023-09-30 $2,902,784 294,400
2023-09-30 $533,426 54,100
2023-06-30 $1,534,474 153,755
2023-06-30 $2,327,336 233,200
2023-06-30 $54,890 5,500
2023-03-31 $911,976 94,800
2023-03-31 $1,093,332 113,652
2023-03-31 $1,918,228 199,400
2022-12-31 $2,938,742 264,038
2022-12-31 $1,732,941 155,700
2022-12-31 $1,272,159 114,300
2022-09-30 $5,833,644 684,700
2022-09-30 $259,860 30,500
2022-06-30 $1,746,396 166,800
2022-06-30 $52,350 5,000
2022-03-31 $1,336,064 122,800
2022-03-31 $978,112 89,900
2021-12-31 $877,853 64,882
2021-12-31 $576,378 42,600
2021-12-31 $2,596,407 191,900
2021-09-30 $8,644,900 638,000
2021-09-30 $1,455,676 107,430
2021-09-30 $7,295,320 538,400

Report a Problem

Category
Description
Email (optional, for follow-up)